These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 20396675)

  • 21. Myostatin, follistatin and activin type II receptors are highly expressed in adenomyosis.
    Carrarelli P; Yen CF; Arcuri F; Funghi L; Tosti C; Wang TH; Huang JS; Petraglia F
    Fertil Steril; 2015 Sep; 104(3):744-52.e1. PubMed ID: 26086422
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proteomic identification and functional validation of activins and bone morphogenetic protein 11 as candidate novel muscle mass regulators.
    Souza TA; Chen X; Guo Y; Sava P; Zhang J; Hill JJ; Yaworsky PJ; Qiu Y
    Mol Endocrinol; 2008 Dec; 22(12):2689-702. PubMed ID: 18927237
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Possible role of TIEG1 as a feedback regulator of myostatin and TGF-beta in myoblasts.
    Miyake M; Hayashi S; Iwasaki S; Chao G; Takahashi H; Watanabe K; Ohwada S; Aso H; Yamaguchi T
    Biochem Biophys Res Commun; 2010 Mar; 393(4):762-6. PubMed ID: 20171187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Skeletal muscle-derived progenitors capable of differentiating into cardiomyocytes proliferate through myostatin-independent TGF-beta family signaling.
    Nomura T; Ueyama T; Ashihara E; Tateishi K; Asada S; Nakajima N; Isodono K; Takahashi T; Matsubara H; Oh H
    Biochem Biophys Res Commun; 2008 Jan; 365(4):863-9. PubMed ID: 18047832
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of myostatin signaling by c-Jun N-terminal kinase in C2C12 cells.
    Huang Z; Chen D; Zhang K; Yu B; Chen X; Meng J
    Cell Signal; 2007 Nov; 19(11):2286-95. PubMed ID: 17689926
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An activin-A/C chimera exhibits activin and myostatin antagonistic properties.
    Muenster U; Harrison CA; Donaldson C; Vale W; Fischer WH
    J Biol Chem; 2005 Nov; 280(44):36626-32. PubMed ID: 16129674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Co-Administration of Myostatin-Targeting siRNA and ActRIIB-Fc Fusion Protein Increases Masseter Muscle Mass and Fiber Size.
    Bayarsaikhan O; Kawai N; Mori H; Kinouchi N; Nikawa T; Tanaka E
    J Nutr Sci Vitaminol (Tokyo); 2017; 63(4):244-248. PubMed ID: 28978871
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activins, myostatin and related TGF-beta family members as novel therapeutic targets for endocrine, metabolic and immune disorders.
    Tsuchida K
    Curr Drug Targets Immune Endocr Metabol Disord; 2004 Jun; 4(2):157-66. PubMed ID: 15180456
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Inhibitory Core of the Myostatin Prodomain: Its Interaction with Both Type I and II Membrane Receptors, and Potential to Treat Muscle Atrophy.
    Ohsawa Y; Takayama K; Nishimatsu S; Okada T; Fujino M; Fukai Y; Murakami T; Hagiwara H; Itoh F; Tsuchida K; Hayashi Y; Sunada Y
    PLoS One; 2015; 10(7):e0133713. PubMed ID: 26226340
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myostatin and follistatin expression in skeletal muscles of rats with chronic heart failure.
    Lima AR; Martinez PF; Okoshi K; Guizoni DM; Zornoff LA; Campos DH; Oliveira SA; Bonomo C; Pai-Silva MD; Okoshi MP
    Int J Exp Pathol; 2010 Feb; 91(1):54-62. PubMed ID: 20002838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional redundancy of type I and type II receptors in the regulation of skeletal muscle growth by myostatin and activin A.
    Lee SJ; Lehar A; Liu Y; Ly CH; Pham QM; Michaud M; Rydzik R; Youngstrom DW; Shen MM; Kaartinen V; Germain-Lee EL; Rando TA
    Proc Natl Acad Sci U S A; 2020 Dec; 117(49):30907-30917. PubMed ID: 33219121
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myostatin promotes a fibrotic phenotypic switch in multipotent C3H 10T1/2 cells without affecting their differentiation into myofibroblasts.
    Artaza JN; Singh R; Ferrini MG; Braga M; Tsao J; Gonzalez-Cadavid NF
    J Endocrinol; 2008 Feb; 196(2):235-49. PubMed ID: 18252947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monitor of the myostatin autocrine action during differentiation of embryonic chicken myoblasts into myotubes: effect of IGF-I.
    Kurokawa M; Sato F; Aramaki S; Soh T; Yamauchi N; Hattori MA
    Mol Cell Biochem; 2009 Nov; 331(1-2):193-9. PubMed ID: 19466527
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Crystal structure of the WFIKKN2 follistatin domain reveals insight into how it inhibits growth differentiation factor 8 (GDF8) and GDF11.
    McCoy JC; Walker RG; Murray NH; Thompson TB
    J Biol Chem; 2019 Apr; 294(16):6333-6343. PubMed ID: 30814254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myostatin inhibition by a follistatin-derived peptide ameliorates the pathophysiology of muscular dystrophy model mice.
    Tsuchida K
    Acta Myol; 2008 Jul; 27(1):14-8. PubMed ID: 19108572
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of GDF-11 and myostatin activity by GASP-1 and GASP-2.
    Lee YS; Lee SJ
    Proc Natl Acad Sci U S A; 2013 Sep; 110(39):E3713-22. PubMed ID: 24019467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Embryonic overexpression of Galgt2 inhibits skeletal muscle growth via activation of myostatin signaling.
    Chandraskeharan K; Martin PT
    Muscle Nerve; 2009 Jan; 39(1):25-41. PubMed ID: 19086062
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of myostatin and activin receptor IIB in the regulation of unloading-induced myofiber type-specific skeletal muscle atrophy.
    Babcock LW; Knoblauch M; Clarke MS
    J Appl Physiol (1985); 2015 Sep; 119(6):633-42. PubMed ID: 26205544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myostatin knockdown and its effect on myogenic gene expression program in stably transfected goat myoblasts.
    Patel AK; Tripathi AK; Patel UA; Shah RK; Joshi CG
    In Vitro Cell Dev Biol Anim; 2014 Aug; 50(7):587-96. PubMed ID: 24682647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery of a follistatin-derived myostatin inhibitory peptide.
    Saitoh M; Takayama K; Hitachi K; Taguchi A; Taniguchi A; Tsuchida K; Hayashi Y
    Bioorg Med Chem Lett; 2020 Feb; 30(3):126892. PubMed ID: 31874826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.